NEW YORK (GenomeWeb News) – OpGen today announced the creation of a public health consortium to evaluate its Whole Genome Mapping technology for strain typing microorganisms that cause health outbreaks.

Members of the consortium are the Association of Public Health Laboratories; the Centers for Disease Control and Prevention; the University of Maryland Institute for Genome Sciences; and 11 state public health laboratories.

The consortium's aim is to show that OpGen's Whole Genome Mapping is a more effective genomic analysis technology for outbreak analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

Nature News writes that researchers are still wrangling over the role of the p-value.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.